Syfovre 15 mg / 0.1 mL injection for intravitreal use Images
Generic Name: pegcetacoplan
This medication has been identified as Syfovre 15 mg / 0.1 mL injection for intravitreal use. It is supplied by Apellis Pharmaceuticals, Inc.
Syfovre is used in the treatment of Geographic Atrophy; Macular Degeneration and belongs to the drug class miscellaneous ophthalmic agents. Syfovre 15 mg / 0.1 mL injection for intravitreal use is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Syfovre
- Generic Name
- pegcetacoplan
- Strength
- 15 mg / 0.1 mL injection for intravitreal use
- Availability
- Prescription only
- Drug Class
- Miscellaneous ophthalmic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apellis Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 73606-0020
More about Syfovre (pegcetacoplan ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous ophthalmic agents
- Breastfeeding
- En español
Patient resources
Professional resources
- Syfovre Injection prescribing information
- Pegcetacoplan (Geographic Atrophy) (Local) (AHFS Monograph)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.